EyePoint Pharmaceuticals, Inc. Quarterly Debt-to-equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
EyePoint Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q2 2024.
  • EyePoint Pharmaceuticals, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 45.5 %, a 53.8% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 45.5 -53 -53.8% Jun 30, 2024
Q1 2024 61.4 -9.2 -13% Mar 31, 2024
Q4 2023 83.6 +24 +40.4% Dec 31, 2023
Q3 2023 131 +80.2 +159% Sep 30, 2023
Q2 2023 98.5 +45.7 +86.5% Jun 30, 2023
Q1 2023 70.6 +15.4 +27.8% Mar 31, 2023
Q4 2022 59.5 -0.09 -0.15% Dec 31, 2022
Q3 2022 50.5 -36.9 -42.2% Sep 30, 2022
Q2 2022 52.8 -62.1 -54% Jun 30, 2022
Q1 2022 55.2 -136 -71.1% Mar 31, 2022
Q4 2021 59.6 -521 -89.7% Dec 31, 2021
Q3 2021 87.5 -632 -87.8% Sep 30, 2021
Q2 2021 115 -457 -79.9% Jun 30, 2021
Q1 2021 191 -178 -48.2% Mar 31, 2021
Q4 2020 580 +231 +66.1% Dec 31, 2020
Q3 2020 719 +494 +220% Sep 30, 2020
Q2 2020 572 +417 +269% Jun 30, 2020
Q1 2020 369 +195 +112% Mar 31, 2020
Q4 2019 349 +175 +100% Dec 31, 2019
Q3 2019 225 +34.8 +18.3% Sep 30, 2019
Q2 2019 155 -130 -45.6% Jun 30, 2019
Q1 2019 174 +35.9 +26% Mar 31, 2019
Q4 2018 175 +132 +312% Dec 31, 2018
Q3 2018 190 +151 +380% Sep 30, 2018
Q2 2018 285 +238 +507% Jun 30, 2018
Q1 2018 138 +88.3 +177% Mar 31, 2018
Q4 2017 42.4 -4.46 -9.53% Dec 31, 2017
Q3 2017 39.6 -13.4 -25.3% Sep 30, 2017
Q2 2017 47 -0.76 -1.59% Jun 30, 2017
Q1 2017 49.9 +5.72 +12.9% Mar 31, 2017
Q4 2016 46.8 +5.35 +12.9% Dec 31, 2016
Q3 2016 53 +20.3 +62.3% Sep 30, 2016
Q2 2016 47.7 +20.3 +74.2% Jun 30, 2016
Q1 2016 44.2 +15.9 +55.9% Mar 31, 2016
Q4 2015 41.5 +10.6 +34.4% Dec 31, 2015
Q3 2015 32.6 -6.03 -15.6% Sep 30, 2015
Q2 2015 27.4 -26.1 -48.7% Jun 30, 2015
Q1 2015 28.4 -33.9 -54.5% Mar 31, 2015
Q4 2014 30.9 -41.6 -57.4% Dec 31, 2014
Q3 2014 38.7 -29.8 -43.5% Sep 30, 2014
Q2 2014 53.5 -9.57 -15.2% Jun 30, 2014
Q1 2014 62.3 +8.97 +16.8% Mar 31, 2014
Q4 2013 72.4 +24 +49.5% Dec 31, 2013
Q3 2013 68.4 +23.2 +51.3% Sep 30, 2013
Q2 2013 63 +27.4 +76.9% Jun 30, 2013
Q1 2013 53.3 +23.1 +76.5% Mar 31, 2013
Q4 2012 48.4 Dec 31, 2012
Q3 2012 45.2 Sep 30, 2012
Q2 2012 35.6 Jun 30, 2012
Q1 2012 30.2 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.